• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Pharos Capital’s Complete Health Acquires Birmingham Internal Medicine Associates

Share:

December 16, 2019

Primary Care Platform Promotes and Expands Value-Based Care Model

Pharos Capital Group, LLC (“Pharos”), a private equity firm based in Dallas and Nashville, announced that its primary care group platform, Complete Health, has acquired Birmingham Internal Medicine Associates (“BIMA”), a provider of specialized and expanded primary care services in Birmingham, Alabama. Terms of the transaction were not disclosed.

“As the initial contact point for patients, primary care will increasingly function as the gatekeeper for care coordination and will be the driver of healthcare cost reduction,” said Anna Kovalkova, Partner at Pharos. “Through Complete Health, we are excited to offer a quality-focused and value-oriented healthcare approach, which we believe will transform sustainable care in the U.S.”

Founded in 1997, BIMA is a provider of specialized and expanded primary care services, including diagnostic imaging, chronic-care management, weight loss management, wellness, virtual office visits and risk assessments for seniors. Founder Dr. John Farley, M.D. and his partners, Drs. Tammy Leong, M.D., Neil Meadows, M.D. and Jason Smith, M.D., will continue leading the practice with the existing team and staff. Dr. Farley has also been named President of the Alabama Markets for Complete Health.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Dr. Farley said, “Complete Health and Pharos are aligned with our belief that the more we can understand and address our patients’ overall needs in one place, through one integrated provider, the more we can focus on getting them proper care that will lead to better outcomes and overall healthier lifestyles. We are proud to become a Complete Health practice.”

Jeff Preuss, Complete Health CEO, commented, “Complete Health’s value-based care concept employs a holistic approach that asks, ‘How can we keep our patients healthy?’ This innovative care model seeks to coordinate comprehensive care, focusing on wellness, and has already been successfully deployed in Florida. We look forward to exporting this progressive and exciting model to Alabama and beyond.”

In 2018, Complete Health was established via its acquisition of Ormond Medical Arts (“OMA”), a primary care clinic in Daytona, FL. Founded in 1973 by Dr. James Shoemaker, DO, OMA is a physician-centric, professionally managed, primary care group delivering exceptional quality care, support service and outcomes. Focusing on prevention, OMA offers onsite diagnostic tests including labs, x-rays and ultrasounds as well as a robust clinical research offering.

Dr. Shoemaker added, “At a time when Americans spend approximately $250 billion on primary care physicians, we believe that spending should result in better overall health. Our goal is to offer preventive care and quality outcomes, patient service excellence, and reduce the physician administrative burden – all while lowering the total cost of care.”

Complete Health is the eleventh platform portfolio investment from Pharos III and III-A, healthcare-focused private equity sister funds. Other recent Pharos investments include Charter Health Care Group, a provider of post-acute care services; Behavior Care Specialists, a provider of autism spectrum disorder services and an addition to Pharos’s Family Treatment Network platform; and Verdi Oncology, an oncology practice and clinical research management company.

Source: Prnews Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • FDA, NIH’s Newest App Asks Clinicians to Log Case Data When Treating Difficult InfectionsFDA, NIH’s Newest App Asks Clinicians to Log Case Data When Treating Difficult Infections
  • Biosimilars: Top 10 Pharma Companies Leading the WayBiosimilars: Top 10 Pharma Companies Leading the Way
  • Fast-Growing Health Recovery Solutions Raises $10M For Remote Patient MonitoringFast-Growing Health Recovery Solutions Raises $10M For Remote Patient Monitoring
  • Laguna Health Launches App-Based Digital Care for Post-Hospital Recovery at NorthshoreLaguna Health Launches App-Based Digital Care for Post-Hospital Recovery at Northshore
  • Novo Nordisk and Noom to Partner Around Digital Health Solutions to Help People With Obesity Lose Weight and Keep it OffNovo Nordisk and Noom to Partner Around Digital Health Solutions to Help People With Obesity Lose Weight and Keep it Off
  • Baxter Completes Acquisition of Seprafilm Adhesion BarrierBaxter Completes Acquisition of Seprafilm Adhesion Barrier
  • Crystal Pharmatech Recognized as “Best Partner” by Allorion Therapeutics for Excellent ServicesCrystal Pharmatech Recognized as “Best Partner” by Allorion Therapeutics for Excellent Services
  • Ligand to Acquire Pfenex Inc.Ligand to Acquire Pfenex Inc.

Trending This Week

  • Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market
  • Life Launches AI Clinical Trial Matching Assistant for Cancer
  • 79% of Healthcare Execs Believe Most Drug Diversion Goes Undetected
  • Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
  • FDA Releases Updated Final Guidance for its Breakthrough Devices Program

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications